GLP-1 receptor agonists like Ozempic and Wegovy have become increasingly popular for weight management and diabetes control, but users are reporting unexpected adverse effects that deserve medical attention. Beyond gastrointestinal issues, emerging reports highlight less discussed complications affecting patient quality of life. Healthcare providers and patients must understand the full spectrum of potential side effects to make informed treatment decisions and monitor symptoms effectively during therapy.

Summary auto-generated by AI from the original publisher's content. Editorial standards.